Liver is exposed to changing metabolic and inflammatory environments. It must sense and adapt 26 to metabolic need while balancing resources required to protect itself from insult. PGC-1α is a 27 transcriptional coactivator that both coordinates metabolic adaptation to diverse stimuli and 28 protects against inflammation in several tissues. However, it is not known how PGC-1α integrates 29 extracellular signals to balance metabolic and anti-inflammatory outcomes. PGC-1α exists as 30 multiple, alternatively spliced variants expressed from different promoters. We show in human 31 liver, NALFD/NASH preferentially activated the alternative PPARGC1A promoter. Gene 32 expression analysis in primary mouse hepatocytes identified shared and isoform-specific roles 33 for PGC-1α variants in response to TNFα. PGC-1α1 primarily impacted gene programs of nutrient 34 and mitochondrial metabolism, while TNFα signaling revealed that PGC-1α4 influenced several 35 pathways related to innate immunity and cell death. Gain-and loss-of-function models showed 36 that PGC-1α4 specifically enhanced expression of anti-apoptotic gene programs and attenuated 37 hepatocyte apoptosis in response to TNFα or LPS. This was in contrast to PGC-1α1, which 38
Clustering based on PGC-1a4-regulated genes was performed using dChip software. Over-177 representation analysis (ORA) of Gene Ontology processes was performed using ClusterProfiler 178 and the mouse genome-wide annotation in R (www.r-project.org). The top 10 statistically over-179
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212
Loss of hepatic PGC-1α results in increased inflammatory damage to liver 213
Over-expression of PGC-1α inhibits NF-κB and increases anti-inflammatory cytokines 214 (Buler et al., 2012; Eisele et al., 2013; Rao et al., 2014) . Consistently, low PGC-1a increases 215 10 et al., 2017), but it is not known whether altered PGC-1α expression influences inflammatory 217 liver damage. To investigate this, we subjected male mice with hepatocyte-specific deletion of the 218 Ppargc1a (PGC-1α) gene (LKO mice) to 6-weeks of a methionine-choline-deficient (MCD) diet, a 219 murine model of inflammatory steatohepatitis. LKO mice had higher circulating levels of alanine 220 aminotransferase (ALT) 42 days after initiation of the diet compared to sex-and age-matched 221 littermate wild-type (WT) controls ( Fig 1A) , suggesting that loss of hepatic PGC-1α aggravates 222 liver damage within a setting of steatosis and inflammation. 223
224
PGC-1a1 and PGC-1a4 are expressed in inflamed liver 225
We next investigated whether hepatic PGC-1α expression associated with liver 226 inflammation. PGC-1α proteins at molecular weights (MW) of ~110 kDa and ~37 kDa were 227 immunoprecipitated at higher levels from mouse liver tissue fifteen days after initiation of the 228 MCD diet compared to control diet-fed mice ( Fig 1B) , concurrent with an increase in 229 inflammatory markers ( Fig 1C) . Multiple splice variants of PGC-1α have been identified that are 230 transcribed from proximal or alternative promoters (Felder et Consistent with protein levels (Fig 1B) , transcripts for Pgc-1α1 and Pgc-1α4 were 246 increased in wild-type mouse livers after initiation of MCD diet and concurrent with increased 247 inflammatory markers ( Fig 1D) . Interestingly, only transcripts from the alternative promoter 248 (containing exons 1b and 1b') were increased in liver samples of human subjects with biopsy-249 confirmed inflammatory liver disease (i.e. NAFLD, NASH or cirrhosis) compared to livers with 250 simple steatosis (low) (Supplemental Fig. S3 ). Of these, we found PGC-1α4 transcript levels 251 increased proportionally with the severity of inflammatory liver disease, with significantly higher 252 mRNA levels detected in cirrhotic liver ( Fig 1E) . In contrast, transcripts from the proximal 253 promoter trended downward in human samples (Supplemental Fig. S3 , Fig 1E) . Taken together, 254 our data suggest that inflammation differentially regulates PGC-1α variant expression and that 255 the alternative PPARGC1A promoter is activated in hepatic inflammatory disease, leading to 256 increased PGC-1α4. 257
258
PGC-1α1 and PGC-1α4 have distinct roles in the hepatic response to TNFα 259
Since PGC-1α isoforms can have overlapping and distinct biological activity (Martinez-260 Redondo et al., 2015), we sought to determine whether PGC-1α1 and PGC-1α4 influence 261 inflammatory signaling pathways. We first compared the transcriptome of primary mouse 262 hepatocytes by microarray following over-expression of PGC-1α1, PGC-1α4, or vector alone in the 263 absence or presence of the inflammatory cytokine, tumor necrosis factor (TNFα) (GEO#:TBD) 12 (Supplemental Fig. S4 ). More than 1000 genes changed by ≥2-fold following PGC-1α1 over-265 expression compared to vector alone (p<0.05, FDR<0.01), while only 24 were changed by PGC-266 1α4 and only 4 genes overlapped between the two lists ( TNFα treatment, >4500 genes were changed ≥2-fold in hepatocytes over-expressing PGC-1α1 268 and >3000 for PGC-1α4, with 36% of the genes shared between isoforms ( 3). This is consistent with known roles of PGC-1a1 on mitochondrial metabolism and supported 281 by qPCR (Supplemental Fig. S5 ). Although we saw no effect of PGC-1a4 on these PGC-1a1 target 282 genes, PGC-1α1 and PGC-1α4 shared many overlapping gene sets (Supplemental File 3). GSEA for 283 PGC-1α4 in untreated hepatocytes centered on lipid metabolism (fatty acids and triglycerides), 284 sterol metabolism and mitochondrial respiration, but individual gene effects were mild and most 285 did not reach the 2-fold cut-off. However, when TNFα was present, PGC-1α4-enriched pathways 286 included regulation of transcription factor transport to the nucleus, innate immunity, responses 287 to interferon/PAMP, TLR signaling, acute inflammation, and apoptosis. Overall, TNFα signaling revealed isoform-specific responses and highlighted processes related to the innate immune 289 response and cell death unique to PGC-1α4. 290
To explore differential effects of the isoforms on inflammation, we performed gene 291 ontology (GO) analysis on gene changes occurring only in the presence of TNFα. Top 10 GO 292 pathways unique to each variant, or shared, are shown in Fig 2C. All of the top PGC-1α1-regulated 293 processes focused on energy metabolism and were shared with PGC-1α4. However, 6 of the top 294 pathways for PGC-1α4 were unique to this variant, including 6-carbon sugar metabolism, 295 proteolysis, immune signaling in response to pathogens, and regulation of cell death ( Fig 2C) . 296
Interestingly, GO terms associated with the 175 shared genes regulated in an opposite manner by 297 the variants (Supplemental File 4) centered mainly on cell death and apoptosis ( Fig 2D) . These 298 data suggest that apoptosis is an important effector pathway differentially regulated by these two 299 PGC-1α protein variants. 300 301
TNFα signaling influences localization of PGC-1α4 within liver cells 302
TNFα treatment substantially increased the number of PGC-1α4 gene targets, revealing 303 that external signals such as inflammation might be necessary for PGC-1α4 activity. Over-304 expressed PGC-1α4 localized primarily to the cytoplasm of H2.35 liver cells; therefore, nuclear 305 exclusion might explain why increased PGC-1α4 has little effect on basal gene expression in 306 untreated hepatocytes (Fig 2A) . Following addition of TNFα to media, a significant proportion of 307 PGC-1α4 was observed in the perinuclear and nuclear compartments ( Fig 3A) . Cell fractionation 308 confirmed that PGC-1α4 protein was only detected in the nuclear pellet following TNFα 309 treatment ( Fig 3B) . In contrast, PGC-1α1 localized exclusively to the nucleus of liver cells 310 regardless of treatment condition ( Fig 3A) . Total levels of both PGC-1α1 and PGC-1α4 modestly 311 increased with short-term TNFα exposure. 14 313 314
Increased PGC-1α4 prevents hepatocyte apoptosis in response to inflammatory signaling 315
Data so far suggested that different PGC-1α isoforms influence inflammatory and anti-316 apoptotic signals in liver cells. Using gain-and loss-of-function models, we investigated whether 317 PGC-1α1 or PGC-1α4 impacted cell death downstream of inflammatory signals in vitro and in vivo. for hepatic PGC-1α4, there were reduced levels of cleaved caspase 3 in livers of both male and 329 female PGC-1α4 HepTg mice following injection of LPS ( Fig 4F) . 330
Consistent with gain-of-function studies, mice lacking PGC-1α in liver had increased 331 cleaved caspase 3 levels when exposed to LPS ( Fig 5A) . However, this knockout model ablates all 332
Ppargc1a transcripts, making it impossible to discern roles for any specific isoform. Thus, we 333 created a mouse model where only the alternative promoter of Ppargc1a was disrupted in a 334 tissue-specific manner (AltProm FL/FL ), blunting expression of transcripts containing exon 1b and 335 knockout, primary hepatocytes from control and KO mice were treated with glucagon, which 337 significantly induced expression of multiple PGC-1α transcripts ( Fig 5C) and proteins ( Fig 5D) 338 from both the proximal and alternative promoter in control AltProm FL/FL cells. In contrast, 339 ablation of the alternative promoter by crossing floxed mice with Alb-Cre Tg mice (AlbPromKO) 340 blunted induction of alternative transcripts in response to glucagon, yet increases in proximal 341 transcripts were similar to (or even higher than) control cells ( Fig 5C) . The 37kD PGC-1α protein 342 induced by glucagon was almost completed ablated by knockout of the alternative promoter, 343
identifying PGC-1α4 as the predominant truncated PGC-1α variant responsive to glucagon in liver 344 cells ( Fig 5D) . Consistent with PGC-1α4 being involved in prevention of apoptosis, hepatocytes 345 from AlbPromKO mice had higher basal and TNFα-induced cleaved caspase 3 levels ( Fig 5E) and 346 increased fragmented nucleosomes in response to inflammatory signaling ( Fig 5F) Table S4 ) and DiRE (Supplemental Fig. S6 ). A significant 356 number of genes unique to PGC-1α1 contained elements corresponding to ETV6 (TEL) binding 357 sites, a member of the ETS transcription factor family not previously associated with PGC-1α 358 activity. IRF4 motifs were enriched in genes shared by PGC-1α1 and PGC-1α4, consistent with 359 previous findings (Kong et al., 2014) . However, many other novel motifs were enriched in this subgroup, including those for ELK4, NR1H2 (LXRb), ZBTB33 (KAISO), ZFP143, and PITX2. In 361 contrast, genes unique to PGC-1α4 were enriched in motifs for SP4, the NFY complex (NFYC/A), 362 IRF6, GM7148 (TGIF2), PITX2, HSF4, and E2F1DP1. Among the 175 genes oppositely regulated 363 by the variants, a unique set of motifs were identified, including binding sites for STAT, SPIB, 364 NFATC2, and KLF4, transcription factors generally involved in cancer progression, apoptosis, and 365 cell cycle. Narrowing our search to motifs within targets implicated in cell survival ( Fig 2D) 366 revealed one transcription factor, ST18 (also known as MYT3 or NZF3), whose predicted binding 367 site was enriched in 16 of these genes. 368
Focusing on the transcription factors with links to apoptosis and cell death, we surveyed 369 whether over-expression of the PGC-1α variants modulated expression of their target genes. SP4 370 and STAT targets were repressed by increased PGC-1α1, but not remarkably changed by over-371 expression of PGC-1α4 (Supplemental Fig. S7A,B ). NFY target genes were regulated similarly by 372 the PGC-1α variants, being generally repressed (Supplemental Fig. S7C ). IRF4 targets Tnfrsf17 373 and Nip3 were increased by PGC-1α1, but not regulated by PGC-1α4 or TNFα treatment 374 (Supplemental Fig. S7D ). Myc, Cdkn2a, Nfil3, and Casp3 expression were unchanged. PGC-1α1 375 alone increased ST18 targets Gata3, Foxc1 and Atad3a and repressed most other target genes 376 (Supplemental Fig. S7E ). 377
So far, our data illustrated that PGC-1α1 and PGC-1α4 had a variety of effects on 378 expression of multiple mediators of inflammation and apoptosis. However, gene effects seen 379 could not explain opposing effects on cell death observed for the variants in our in vitro models. 380
Searching the microarray for candidate anti-apoptotic genes downstream of PGC-1α4, we 381 identified Birc2 (Ciap1) and Tnfaip3 (also known as A20) ( Fig. 2A) , two anti-apoptotic proteins 382 that prevent cell death downstream of inflammatory signalling. In a separate experiment, we 383 confirmed that their transcript levels were significantly higher in mouse primary hepatocytes 384 over-expressing PGC-1α4 only in the presence of TNFα ( Fig 6A) . Related Birc3 (Ciap2) was also 385 increased by TNFα/PGC-1α4, while Birc5 expression did not change. In addition, transcripts for 386 apoptosis inhibitors Naip and Xiap were significantly increased by PGC-1α4, regardless of TNFα 387 treatment. In contrast, over-expression of PGC-1α1 decreased expression of Birc3, Birc5, and 388 Tnfαip3 ( Fig 6A) and had no effect on Naip and Xiap. 389
Since these genes are all regulated by NF-κB, we hypothesized that PGC-1α4 might 390 enhance NF-κB activity, contrasting with reported repressive effects of PGC-1α1 on this pro-391 inflammatory transcription factor. Basal expression of a 3x NF-κB response element reporter was 392 increased when PGC-1α1 was co-expressed in primary hepatocytes ( Fig 6B) ; yet consistent with 393 TNFα was significantly blunted by high PGC-1α1. PGC-1α4 had no effect on basal or TNFα-395 induced NF-κB reporter activity. Protein levels of p50 were decreased by both PGC-1α1 and PGC-396 1α4 in the presence of TNFα, and p65 remained unchanged in all conditions. Over-expression of 397 PGC-1α1 modestly decreased IKKb and IkBα proteins, which could relieve inhibition on NF-κB 398 and possibly explain increased basal activity. PGC-1α4 over-expression had no effect on these 399 proteins ( Fig 6C) . However, consistent with previous reports, increased PGC-1α1 significantly 400 decreased basal and/or TNFα-induced levels of pro-inflammatory genes Mcp-1, Tnfα, Ikbα and 401
Ccl5 in primary hepatocytes (Fig 6D) , demonstrating a strong inhibitory role on NF-κB target 402 genes. In contrast, PGC-1α4 had little impact on these genes, except to potentiate the Tnfα 403 response similar to the pattern seen on the anti-apoptotic targets (Fig 6A) . 404
In summary, PGC-1α1 had generally repressive effects on transcription of genes involved 405 in inflammation and cell death that were mostly independent of TNFα. In contrast, PGC-1α4 406 differentially enhanced a select program of anti-apoptotic factors in hepatocytes only in the 407 presence of inflammatory signaling. While we identified multiple genes involved in cell survival 408 oppositely regulated by the variants, enrichment of transcription factor motifs did not reveal the 409 mechanism by which PGC-1α4 specifically enhances the anti-apoptotic gene program. 410
DISCUSSION
411
In the current study, we found that various non-canonical PGC-1a protein variants are 412 expressed in inflamed liver and differentially regulate hepatic inflammatory signaling. Gene set 413 enrichment analysis revealed that in the presence of the inflammatory cytokine TNFa, PGC-1a4 414 influences innate immunity and cell death, while PGC-1a1 remains primarily associated with 415 mitochondrial function and metabolic processes. Gene ontology (GO) analysis illustrated that 416 genes implicated in cell death and apoptosis appear to be oppositely regulated by these two 417 variants. In primary liver cells, PGC-1a4 significantly blunted apoptosis in response to TNFa, a 418 function that may be controlled by shuttling of PGC-1a4 between cytoplasm and nucleus. We 419 conclude that alternative forms of PGC-1a are induced in inflammatory environments, giving rise 420 to increased levels of the truncated PGC-1a4 isoform that attenuates apoptosis downstream of 421 inflammatory signaling. These findings give mechanistic insight into how PGC-1a, as a family of 422 proteins, facilitate parallel adaptation to metabolic demand and mitigation of inflammatory 423 damage in cells. 424
Immune responses to danger signals are metabolically challenging and can lead to a trade-425 off between maintaining highly energy demanding processes of nutrient metabolism versus 426 adaptation to inflammatory stimuli (Ganeshan et al., 2019) . Inflammation itself may also inhibit 427 metabolism and impede mitochondrial function. Here, we show that signaling via TNFa or LPS 428 leads to a shift in the PGC-1a gene program downstream of PGC-1a1 and PGC-1a4, ensuring that 429 concurrent inflammatory signaling does not impede the ability to respond to metabolic need. 430
This mechanism represents an additional layer by which the family of PGC-1a proteins help 431 balance an integrated metabolic response modulated by the inflammatory status of the liver. 432
It is now well established that PGC-1a is a family of proteins created by alternative 433 splicing of the PPARGC1A gene in many tissues including skeletal muscle (Martinez-Redondo however, further studies are necessary to confirm this hypothesis. 478 putative phosphorylation (S190, S237, and T252) sites, which regulate nuclear shuttling of NT-481 PGC-1α (Chang et al., 2010) . Our data are consistent with reports describing cytoplasmic to 482 nuclear movement of other truncated variants of PGC-1α (Chang et al., 2010; Zhang et al., 2009). 483 Given similarities between these two proteins, it is possible that NT-PGC-1α localization is also 484 regulated by inflammation similar to PGC-1α4, and while likely, it remains to be seen whether 485
PGC-1α4 and NT-PGC-1α have overlapping functions. 486
We note that only transcripts from the alternative promoter were increased in human 487 NASH and cirrhotic livers, and proximal transcripts appeared to decrease in cirrhosis. This would 488 suggest that inflammatory signals shift preference from the proximal to the alternative PGC-1α 489 promoter and imply that PGC-1α4 (from the alternative promoter) could be the predominant 490 
